The Relationship Between Cannabis Use and Self-Reported Trait Anger in Treatment-Seeking Young People
Cannabis & Cannabinoid Research · 01.02.2024 · 9 (1) · 223-229
DOI: 10.1089/can.2021.0239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cannabis & Cannabinoid Research, online erschienen am 12.02.2024. Verfasst von James W McKowen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Addiction Recovery Management Service and West End Clinic, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Cannabis, Marijuana Abuse, Substance-Related Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
Objective
Trait anger has been shown to be predictive of emotion-focused coping and alcohol use. Yet, the connection between cannabis use and trait anger remains poorly characterized. The present study sought to investigate the relationship between cannabis use and self-reported trait anger in youth seeking substance use treatment.
Methods
A retrospective chart review was conducted on youth ( n =168) aged 14–26 presenting for an initial evaluation at an outpatient substance use treatment program. Patients self-reported trait anger score (TAS) and lifetime, recent, and Diagnostic and Statistics Manual-5th Edition diagnostic status of cannabis use were assessed. Clinician-coded psychiatric and substance use patterns were collected, along with urine carboxy delta-9-tetrahydrocannabinol (THC) concentration levels. Additional measures of anxiety, depression, and demographic variables were assessed.
Results
Higher self-reported TAS were associated with cannabis use, cannabis use disorder (CUD), and more recent and frequent cannabis use. The presence of a CUD was independently associated with TAS after controlling for the presence of other substance use disorders and co-occurring depression and anxiety disorders. Higher urine THC concentration levels were associated with higher TAS.
Conclusions
Findings support an association between heavy, chronic cannabis use and elevated self-reported trait anger at intake. There may be important neurological consequences of heavy, chronic cannabis use that impact anger regulation. It is also plausible that trait anger maybe a predisposing factor for elevated cannabis use. Better controlled prospective research is needed to help determine directionality. Treatment programs should target both cannabis use and anger regulation in youth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Addiction Recovery Management Service and West End Clinic, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Psychiatry, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts, USA.
ORCID-Profile: James W McKowen
Förderung
- NIDA NIH HHS
Zitieren
APA
McKowen, J. W., Lowman, K. L., Watt, L., Yule, A. M., Burke, C., Kaminiski, T., Wilens, T., & Kelly, J. (2024). The Relationship Between Cannabis Use and Self-Reported Trait Anger in Treatment-Seeking Young People. Cannabis & Cannabinoid Research, 9(1), 223-229. https://doi.org/10.1089/can.2021.0239
Vancouver
McKowen JW, Lowman KL, Watt L, Yule AM, Burke C, Kaminiski T, et al. The Relationship Between Cannabis Use and Self-Reported Trait Anger in Treatment-Seeking Young People. Cannabis & Cannabinoid Research. 2024;9(1):223-229. doi:10.1089/can.2021.0239
BibTeX
@article{McKowen2024,
author = {McKowen, James W and Lowman, Kelsey L and Watt, Lisa and Yule, Amy M and Burke, Colin and Kaminiski, Tamar and Wilens, Timothy and Kelly, John},
title = {The Relationship Between Cannabis Use and Self-Reported Trait Anger in Treatment-Seeking Young People},
journal = {Cannabis & Cannabinoid Research},
year = {2024},
volume = {9},
number = {1},
pages = {223--229},
doi = {10.1089/can.2021.0239}
}
EUVIMED